Effects of Romantic Affection on Blood Chemistry and Immune Parameters
NCT ID: NCT00482404
Last Updated: 2007-06-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
EARLY_PHASE1
INTERVENTIONAL
2007-02-28
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Romantic kissing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking;
* Current co-habitation with romantic partner
Exclusion Criteria
* Current pregnancy;
* Current use of blood-thinning agents;
* Greater than moderate anxiety about giving capillary blood;
* Weight of less than 110 pounds
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Arizona State University
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kory Floyd, PhD
Role: PRINCIPAL_INVESTIGATOR
Arizona State University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1001 R03 MH075757-01A1
Identifier Type: -
Identifier Source: org_study_id